Antares Therapeutics

United States
Panora, Iowa, United States, 02110

Company profile

Antares Therapeutics company profile

Antares Therapeutics is a biotechnology company focused on developing transformational precision medicines targeting validated but previously undruggable targets in cancer and other serious diseases with significant unmet medical needs. Founded as a spin-out from Scorpion Therapeutics, it leverages proprietary drug discovery capabilities and a robust preclinical pipeline to advance multiple programs, primarily in precision oncology.

Business identity

Phone number
+1 781-288-5760
Operating status
Active
Company type
For Profit
Employee range
101-250 employees
Founded
2025-01-01, Year

Headquarters

Postal code
02110
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
Early Stage Venture
Funding rounds
1
Total equity funding
$177M
Last funding
Series A / $177M / 2025-05-15
Last equity funding
Series A / $177M
Investors
11
Lead investors
5
Articles
18

Founders and investors

Lead investors

Atlas VentureBiotechnology Value FundCormorant Asset ManagementLightspeed Venture PartnersOmega Funds

Investors

AbingworthCormorant Asset ManagementLightspeed Venture PartnersOmega FundsVida Ventures